TAFIXYL 100mg/ml Price

Overview

Welcome to Dwaey, specifically on TAFIXYL 100mg/ml Infusion/Solution for page.
This medicine contains an important and useful components, as it consists of Tranexamic acid.
TAFIXYL 100mg/ml is available in the market in concentration 100mg/ml and in the form of Infusion/Solution for.

PHARMA BAVARIA INTERNATIONAL GmbH is the producer of TAFIXYL 100mg/ml and it is imported from GERMANY, The most popular alternatives of TAFIXYL 100mg/ml are listed downward .

Mode Of Action

Tranexamic acid is an antifibrinolytic agent that competitively inhibits breakdown of fibrin clots. It blocks binding of plasminogen and plasmin to fibrin, thereby preventing haemostatic plug dissolution.

Indication

• Haemorrhage
• Hereditary angioedema

Precaution

Mild to moderate renal impairment, irregular menstrual bleeding, previous history of thromboembolic disease, haematuria. Monitor closely in disseminated intravascular coagulation. Monitor LFT and eye examination regularly during long-term use. Discontinue if disturbance in colour vision occurs. Avoid IV inj rate >1 ml/minute due to risk of hypotension. Pregnancy, lactation.

Side Effects

• >10% Headache (50.4%)
• Nasal and sinus symptoms (25.4%)
• Back pain (20.7%)
• Abdominal pain (19.8%)
• Musculoskeletal pain (11.2%) 1-10% Arthralgia (6.9%)
• Muscle cramps and spasms (5.8%)
• Migraine (6%)
• Anemia (5.6%)
• Fatigue (5.2%) Frequency Not Defined Visual abnormalities
• Hypotension (with rapid injection)
• Nausea
• Vomiting
• Diarrhea

Contra indication

Severe renal failure, active intravascular clotting, thromboembolic disease, colour vision disorders, subarachnoid bleeding.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.